Stockscreener 앱 받기
203.48
1.19%
2.39
시간 외 거래:
203.40
-0.08
-0.04%
전일 마감가:
$201.09
열려 있는:
$201.74
하루 거래량:
2.62M
Relative Volume:
1.21
시가총액:
$57.97B
수익:
$21.84B
순이익/손실:
$1.68B
주가수익비율:
34.91
EPS:
5.8293
순현금흐름:
$2.67B
1주 성능:
+0.84%
1개월 성능:
+4.01%
6개월 성능:
+12.09%
1년 성능:
-18.11%
1일 변동 폭
$200.11
$204.05
1주일 범위
$199.00
$208.00
52주 변동 폭
$162.29
$251.99
벡톤 디킨슨 Stock (BDX) Company Profile
명칭
Becton Dickinson Co
전화
(201) 847-6800
주소
ONE BECTON DR, FRANKLIN LAKES
BDX을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
BDX
Becton Dickinson Co
|
203.48 | 57.29B | 21.84B | 1.68B | 2.67B | 5.8293 |
|
ISRG
Intuitive Surgical Inc
|
504.22 | 179.92B | 10.06B | 2.88B | 2.27B | 7.8807 |
|
ALC
Alcon Inc
|
80.98 | 39.86B | 10.19B | 1.05B | 1.38B | 2.1044 |
|
RMD
Resmed Inc
|
258.31 | 37.60B | 5.26B | 1.44B | 1.76B | 9.7713 |
|
MDLN
Medline Inc
|
44.20 | 36.39B | 27.43B | 1.27B | 1.01B | 1.5829 |
벡톤 디킨슨 Stock (BDX) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-09-25 | 개시 | RBC Capital Mkts | Sector Perform |
| 2025-05-22 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2025-05-02 | 다운그레이드 | Goldman | Buy → Neutral |
| 2025-05-02 | 다운그레이드 | Piper Sandler | Overweight → Neutral |
| 2025-05-02 | 다운그레이드 | Raymond James | Outperform → Mkt Perform |
| 2025-05-01 | 다운그레이드 | BofA Securities | Buy → Neutral |
| 2025-05-01 | 다운그레이드 | Wells Fargo | Overweight → Equal Weight |
| 2025-05-01 | 다운그레이드 | William Blair | Outperform → Mkt Perform |
| 2024-10-01 | 업그레이드 | Citigroup | Neutral → Buy |
| 2024-05-30 | 개시 | Goldman | Buy |
| 2023-07-24 | 업그레이드 | Raymond James | Mkt Perform → Outperform |
| 2023-05-30 | 재개 | Morgan Stanley | Overweight |
| 2023-05-05 | 업그레이드 | Piper Sandler | Neutral → Overweight |
| 2023-04-12 | 업그레이드 | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2023-01-03 | 업그레이드 | BofA Securities | Neutral → Buy |
| 2022-12-12 | 업그레이드 | Citigroup | Sell → Neutral |
| 2022-07-11 | 다운그레이드 | Citigroup | Neutral → Sell |
| 2022-06-24 | 업그레이드 | Wells Fargo | Equal Weight → Overweight |
| 2022-03-18 | 재개 | Raymond James | Mkt Perform |
| 2022-03-02 | 재개 | BofA Securities | Neutral |
| 2021-12-08 | 다운그레이드 | Piper Sandler | Overweight → Neutral |
| 2021-08-06 | 다운그레이드 | JP Morgan | Overweight → Neutral |
| 2021-05-25 | 개시 | Barclays | Equal Weight |
| 2020-12-15 | 업그레이드 | Morgan Stanley | Equal-Weight → Overweight |
| 2020-12-15 | 다운그레이드 | Wells Fargo | Overweight → Equal Weight |
| 2020-07-09 | 업그레이드 | Barclays | Equal Weight → Overweight |
| 2020-06-01 | 재개 | Goldman | Buy |
| 2020-03-05 | 개시 | Citigroup | Neutral |
| 2020-02-07 | 다운그레이드 | Cowen | Outperform → Market Perform |
| 2020-02-07 | 다운그레이드 | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2020-02-07 | 다운그레이드 | Raymond James | Strong Buy → Outperform |
| 2020-02-06 | 다운그레이드 | Cowen | Outperform → Market Perform |
| 2020-01-08 | 다운그레이드 | Barclays | Overweight → Equal Weight |
| 2019-05-13 | 업그레이드 | Barclays | Equal Weight → Overweight |
| 2018-12-07 | 개시 | Deutsche Bank | Buy |
| 2018-10-16 | 개시 | Barclays | Equal Weight |
| 2018-06-21 | 업그레이드 | JP Morgan | Neutral → Overweight |
| 2018-04-10 | 업그레이드 | Citigroup | Neutral → Buy |
| 2018-01-19 | 재개 | BofA/Merrill | Buy |
| 2018-01-05 | 업그레이드 | Citigroup | Sell → Neutral |
| 2018-01-05 | 개시 | KeyBanc Capital Mkts | Overweight |
| 2018-01-03 | 개시 | Evercore ISI | Outperform |
| 2017-12-29 | 재확인 | Deutsche Bank | Buy |
모두보기
벡톤 디킨슨 주식(BDX)의 최신 뉴스
Becton Dickinson (NYSE:BDX) Will Pay A Dividend Of $1.05 - simplywall.st
Becton Dickinson's (NYSE:BDX) Dividend Will Be $1.05 - Yahoo Finance UK
Becton, Dickinson and Company $BDX Shares Acquired by TD Waterhouse Canada Inc. - MarketBeat
Becton, Dickinson and Company (BDX) Announces Executive Severanc - GuruFocus
Everett Harris & Co. CA Sells 7,344 Shares of Becton, Dickinson and Company $BDX - MarketBeat
Becton Dickinson Reshapes Portfolio With Waters Deal And Recycling Progress - Yahoo Finance UK
Becton Dickinson director Scott Bertram sells $159,593 in stock - MSN
Does The Recent Share Price Slide Make Becton Dickinson (BDX) Look Interesting Again? - simplywall.st
Recycling possible for PS petri dishes, other lab equipment - Plastics News
Becton Dickinson Hit With Lawsuit Over Catheter-Insertion Patent - Bloomberg Law News
The Analyst Verdict: Becton Dickinson In The Eyes Of 7 Experts - Benzinga
Becton, Dickinson and Company (NYSE:BDX) EVP Sells $15,204.75 in Stock - MarketBeat
BD, Waters set completion date for $17.5B biosciences and diagnostics merger - MedTech Dive
Insider Sell: Michael Feld Sells Shares of Becton Dickinson & Co (BDX) - GuruFocus
Feld Michael, evp at Becton Dickinson, sells $15k in stock - Investing.com India
Becton, Dickinson and Company $BDX Shares Sold by Y Intercept Hong Kong Ltd - MarketBeat
Piper Sandler Maintains Becton Dickinson & Co(BDX.US) With Hold Rating, Raises Target Price to $205 - 富途牛牛
How Investors Are Reacting To Becton Dickinson (BDX) Dividend Hike, Buyback Plan And AI-Driven Upgrades - simplywall.st
Becton Dickinson & Co To Go Ex-Dividend On March 10th, 2026 With 1.05 USD Dividend Per Share - 富途牛牛
BD Board Declares Dividend, Authorizes 10 Million Additional Share Repurchases; BD Completed $250 Million Repurchase to Date in FY26 - Benzinga
BECTON, DICKINSON Q1 2026 Earnings Preview: Recent $BDX Insider Trading, Hedge Fund Activity, and More - Quiver Quantitative
$17.5B BD Spinoff Nears Completion - Medical Device and Diagnostic industry
BD Biosciences & Diagnostic Solutions Spin-Off to Combine With Waters in Reverse Morris Trust - citybiz
BD sets date for spin-off of Biosciences & Diagnostics Solutions business to Waters - MassDevice
Waters Shareholders Approve Combination with BD's Biosciences & Diagnostic Solutions Business - Financial Times
(01/27/26) Top Picks 2026: Becton, Dickinson & Co. (BDX) - moneyshow.com
Becton, Dickinson and Company $BDX Holdings Lifted by Sector Gamma AS - MarketBeat
Becton, Dickinson and Company $BDX Shares Purchased by Commerzbank Aktiengesellschaft FI - MarketBeat
BDX and WST Stocks Fall Amid Novo Nordisk's Oral Wegovy Success - GuruFocus
BD Helps Scientists Advance Immunology and Cancer Research with AI-Powered Insights and Automation - Finviz
Becton, Dickinson and Co (NYSE:BDX) Shows High Technical and Setup Ratings for Potential Breakout - Chartmill
BICO company Biosero launches GoSimple™, a standardized automation-ready workcell with selected instruments from Sartorius and Becton, Dickinson and Company (BD) - marketscreener.com
BD and Ypsomed Expand Partnership to Target Growing Biologics Market - Yahoo Finance
RBC Capital Maintains Becton Dickinson & Co(BDX.US) With Hold Rating, Maintains Target Price $210 - 富途资讯
Universal Beteiligungs und Servicegesellschaft mbH Acquires 8,561 Shares of Becton, Dickinson and Company $BDX - MarketBeat
BD and Ypsomed partner to develop 5.5 mL prefillable syringe By Investing.com - Investing.com Nigeria
BD and Ypsomed Expand Partnership to Address Rapidly Growing Biologics Market - Finviz
BD Gets FDA 510(k) Approval for EnCor EnCompass Breast Biopsy System - Yahoo Finance
BD and Ypsomed partner to develop 5.5 mL prefillable syringe - Investing.com
BD and Ypsomed Expand Partnership to Address Rapidly Growing Biologics Market – Company Announcement - Financial Times
Allstate Corp Makes New Investment in Becton, Dickinson and Company $BDX - MarketBeat
BD to Highlight Advanced Biologics and Large-Volume Delivery Solutions at Pharmapack 2026 - BD Newsroom
Becton, Dickinson and Company $BDX Shares Acquired by Massachusetts Financial Services Co. MA - MarketBeat
Microvast, Datavault AI, RH, Becton Dickinson, Verastem Shake-Up - TipRanks
Insider Selling: Becton, Dickinson and Company (NYSE:BDX) EVP Sells 1,610 Shares of Stock - MarketBeat
Becton Dickinson EVP Garrison sells $334,005 in BDX stock - Investing.com India
BD secures FDA 510(k) clearance for EnCor EnCompass system - Yahoo
Lobbying Update: $1,496,000 of BECTON DICKINSON AND COMPANY lobbying was just disclosed - Quiver Quantitative
Becton, Dickinson Wins FDA Clearance For Next-Gen Breast Biopsy Device, Launch Set For 2026 - Benzinga
BD receives FDA clearance for new breast biopsy system By Investing.com - Investing.com India
BD Receives FDA 510(k) Clearance for EnCor EnCompass Breast Biopsy and Tissue Removal System - Finviz
벡톤 디킨슨 (BDX) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.21%
0.27%
자본화:
|
볼륨(24시간):